Sustained and post-treatment efficacy of a 5-grass pollen allergen extract sublingual tablet in adults with grass pollen-induced allergic rhinoconjunctivitis

被引:0
|
作者
Zeldin, R. K.
Melac, M.
Amistani, Y.
Didier, A.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:298 / 298
页数:1
相关论文
共 50 条
  • [31] Efficacy of 300IR 5-grass pollen extract sublingual tablet in patients with grass pollen-associated allergic rhinoconjunctivitis assessed by daily combined score in a long term study
    Didier, A.
    Montagut, A.
    Zeldin, R. K.
    ALLERGY, 2014, 69 : 403 - 404
  • [32] Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit
    Ellis, Anne K.
    Tenn, Mark W.
    Steacy, Lisa M.
    Adams, Daniel E.
    Day, Andrew G.
    Walker, Terry J.
    Nolte, Hendrik
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (05) : 495 - +
  • [33] Efficacy Of 300IR 5-Grass Pollen Sublingual Tablets In Grass Pollen-Associated Allergic Rhinoconjunctivitis: Pooled Analysis By Level Of Pollen Exposure
    Didier, Alain
    Wahn, Ulrich
    Amistani, Yann
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB280 - AB280
  • [34] Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis
    Didier, Alain
    Worm, Margitta
    Horak, Friedrich
    Sussman, Gordon
    de Beaumont, Olivier
    Le Gall, Martine
    Melac, Michel
    Malling, Hans-Jorgen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (03) : 559 - 566
  • [35] SAFETY OVER TIME OF 300IR 5-GRASS POLLEN SUBLINGUAL TABLET IN SUBJECTS WITH ALLERGIC RHINOCONJUNCTIVITIS
    Casale, T.
    Wald, J.
    Renahan, K.
    Abiteboul, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S69 - S69
  • [36] Treatment satisfaction during sublingual immunotherapy with a 5-grass pollen tablet for allergic rhinoconjunctivitis: a prospective, non-interventional study
    Hadler, M.
    Karagiannis, E.
    ALLERGY, 2015, 70 : 258 - 259
  • [37] Efficacy assessment in an allergen challenge chamber (ACC) of sublingual immunotherapy (SLIT) with a 5-grass pollen tablet
    Devillier, P.
    Montagut, A.
    Lheritier-Barrand, M.
    Le Gall, M.
    de Beaumont, O.
    Zieglmayer, R.
    Lemell, P.
    Horak, F.
    ALLERGY, 2009, 64 : 466 - 466
  • [38] Efficacy and safety of 300IR 5-grass pollen sublingual allergen immunotherapy tablets in adult patients with grass-pollen rhinoconjunctivitis in United States
    Cox, L.
    Casale, T.
    Nayak, A.
    Bernstein, D.
    Mekhaldi, S.
    de Beaumont, O.
    Melac, M.
    Montagut, A.
    Creticos, P.
    ALLERGY, 2011, 66 : 63 - 63
  • [39] Sustained efficacy of 300IR sublingual solution of birch pollen extract in adults with birch pollen-induced rhinoconjunctivitis
    Worm, M.
    Melac, M.
    Cadic, V
    Zeldin, R. K.
    ALLERGY, 2013, 68 : 475 - 475
  • [40] An assessment of sustained efficacy and safety of a 300IR five-grass pollen sublingual immunotherapy tablet in adults with grass pollen induced allergic rhinoconjunctivitis during a 3-year treatment study
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Le Gall, M.
    Montagut, A.
    Galvain, S.
    Malling, H.
    ALLERGY, 2010, 65 : 172 - 172